RxDoctor Payments Data

Layne Kitchens

Adult Health · Sandersville, GANPI 1790740819

Payments from drug & device makers

$967in general payments, 2019–2025

Across 49 payments — averaging $19.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$252
  • Kerecis Limited$132
  • GSK$93
  • Merck$79
  • AstraZeneca$75
  • Abbott$60
  • plus $276 from 10 others

What the payments were for

  • Food & beverage$967100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$967 in reported general payments places this provider in the 65th percentile of 577 adult health providers in Georgia.

See all adult health providers in Georgia

Medicare billing

Part B allowed, 2024
$61,963
Medicare patients
164
Services billed
1,210

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide95$107,517
JanuviaSitagliptin Phosphate85$67,204
EliquisApixaban85$65,778
LinzessLinaclotide26$17,642
JardianceEmpagliflozin21$11,860
MyrbetriqMirabegron18$9,605
Lantus SolostarInsulin Glargine,hum.Rec.Anlog46$8,143
Breo ElliptaFluticasone/Vilanterol17$6,686
Lagevrio (Eua)Molnupiravir12$5,374
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog13$4,146
SymbicortBudesonide/Formoterol Fumarate13$3,610
Losartan Potassium225$2,612
Metoprolol Succinate212$2,591
Humalog Mix 75-25 KwikpenInsulin Lispro Protamin/Lispro18$2,585
Gabapentin168$2,497

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$252$107,51795 claims
MerckJanuvia, Lagevrio (Eua)$79$72,57897 claims
Boehringer IngelheimJardiance$16$11,86021 claims
GSKBreo Ellipta$93$6,68617 claims
AstraZenecaSymbicort$75$3,61013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 577 adult health providers in Georgia.

Other adult health in Sandersville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →